KINBREX

This brand name is authorized in Nigeria.

Active ingredients

The drug KINBREX contains one active pharmaceutical ingredient (API):

1	Celecoxib UNII JCX84Q7J1L - CELECOXIB
	Celecoxib is an oral, selective, cyclooxygenase-2 (COX-2) inhibitor within the clinical dose range (200-400 mg daily). No statistically significant inhibition of COX-1 (assessed as ex vivo inhibition of thromboxane B2 [TxB2] formation) was observed in this dose range in healthy volunteers.
	Read more about Celecoxib

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-7856	Capsule	KINBREX CAPSULES CAP 200 mg 1 X 10	190 RNW-PP-287483 KINBREX CAPSULES CELECOXIB 200MG Each hard gelatin capsules contains: Celecoxib 200mg Excipients q.s. Empty gelatin Capsules contains approved colour Ecxipients Lactose monohydrate Hydroxypropyl Cellulose B4-7856 Drugs Imported Products 1x10 Prescription Only Medicine (POM) 10/18/2022 KINGZY PHARMACEUTICALS LIMITED, NO. 142, OKPORO ROAD, PORT HARCOURT, RIVERS STATE, NIGERIA 8060786272 kingzypharmltd@yahoo.com BRUSSELS LABORATORIES PVT. LTD, NO 33, CHANGODAR INDUSTRIAL ESTATE, SARKHEJ BAVIA ROAD, CHANGODAR- 382 210, DIST; AHMEDABAD. INDIA, India	06/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M01AH01	Celecoxib	M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AH Coxibs
Discover more medicines within M01AH01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-7856